Investing Profile

René Kuijten

InvestorVC

Partner, Head of EQT Life Sciences

Your Intro Paths to René Kuijten

Signal uses Gmail to reveal intro paths. Email content is never read.

Find René Kuijten on

Current Investing Position

Investment Range

$11.0M - $65.0M

Sweet Spot

$25.0M

Investments On Record

Current Fund Size

€260M

René Kuijten is on these Sector & Stage Rankings

René Kuijten's Investments On Record (4)

Company	StageDateRound Size	Total Raised
Artios Pharma	Series DNov 2025$120M Series CJul 2021$150M Series BAug 2018$83M	$380M
Co-investors: Nikola Trbovic (Pfizer Venture Investments), Barbara Dalton (Pfizer Venture Investments), Jake Simson (RA Capital), Florian Müllershausen (Novartis Venture Fund), Hakan Goker (M Ventures (Merck)), Raphael Wisniewski (Andera Partners)
Neuravi	Series BJun 2015$22M	$22M
Co-investors: Anne Portwich (EQT Life Sciences)
BMEYE	Series BOct 2009$9M	$9M
Co-investors: Thom Rasche (Earlybird Venture Capital)
Syntaxin	Series BOct 2007$32M	$71M
Co-investors: Genghis Lloyd-Harris (Abingworth), Deborah Harland (SR One)